Co-opting regulation bypass repair as a gene-correction strategy for monogenic diseases
Open Access
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 29 (11) , 3274-3292
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (SCR _014387)
- Pennsylvania State University
- National Institutes of Health (R01 DK88140)
- National Institutes of Health (2UC4DK098085)
This publication has 60 references indexed in Scilit:
- RNA-Guided Human Genome Engineering via Cas9Science, 2013
- Multiplex Genome Engineering Using CRISPR/Cas SystemsScience, 2013
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial ImmunityScience, 2012
- High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy NumberAnalytical Chemistry, 2011
- Efficient gene delivery and silencing of mouse and human pancreatic isletsBMC Biotechnology, 2010
- AAV8-mediated Gene Transfer of Interleukin-4 to Endogenous β-Cells Prevents the Onset of Diabetes in NOD MiceMolecular Therapy, 2008
- In Vitro and In Vivo Gene Therapy Vector Evolution via Multispecies Interbreeding and Retargeting of Adeno-Associated VirusesJournal of Virology, 2008
- PERK eIF2 alpha kinase is required to regulate the viability of the exocrine pancreas in miceBMC Cell Biology, 2007
- Efficient gene delivery to human and rodent islets with double-stranded (ds) AAV-based vectorsGene Therapy, 2005
- Diabetes Mellitus and Exocrine Pancreatic Dysfunction in Perk−/− Mice Reveals a Role for Translational Control in Secretory Cell SurvivalMolecular Cell, 2001